1.
Bimekizumab Remission and High Disease Control Over 4 years in Patients with Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 29];10(2):s758. Available from: https://skin.dermsquared.com/skin/article/view/4085